| [1] |
FANG Yanhui , MA Caijuan , ZHANG Chunli , ZHAI Jiawei , ZHU Qiaoying , LIU Yin , ZHAO Xiwa .
miR-496 inhibits proliferation, migration and invasion of HeLa cell in cervical cancer via SFMBT1
[J]. China Oncology, 2021, 31(8): 697-703.
|
| [2] |
LONG Xingtao , ZHOU Qi , WANG Dong , CHEN Yuemei , JIN Fujun .
The prognostic value of revised 2018 FIGO stage ⅢC in cervical cancer
[J]. China Oncology, 2021, 31(8): 725-733.
|
| [3] |
DONG Shijie, HU Xiaoxin, WANG Wei, YANG Meng, YUE Lei, TONG Tong, GU Yajia.
Prediction of lymph node metastasis of cervical cancer based on multi-sequence MRI and multi-system imaging omics model
[J]. China Oncology, 2021, 31(6): 460-467.
|
| [4] |
ZHU Jun, WU Xiaohua.
Leading research progress and prospect of gynecological oncology in 2020
[J]. China Oncology, 2021, 31(4): 250-256.
|
| [5] |
SHEN Jie , MO Miao , YUAN Jing , ZHOU Changming , WANG Zezhou , ZHANG Zhihong , WEN Hao , WU Xiaohua , ZHENG Ying .
Long-term survival report on 1 313 patients with locally advanced cervical cancer: a hospital-based real world study
[J]. China Oncology, 2020, 30(3): 192-198.
|
| [6] |
CHEN Xiaohui, WANG Jiazhou, HU Weigang, PENG Jiayuan, ZHAI Peng.
Dosimetric impact of machine and treatment planning system on knowledge-based planning: a study based on cervical cancer IMRT plan
[J]. China Oncology, 2020, 30(10): 821-825.
|
| [7] |
LIU Shan, FANG Juan, WANG Lili, ZHANG Yinghong, DU Wenjie, ZHU Taohua.
Association between peripheral nerve invasion and recurrence risk factors in cervical cancer
[J]. China Oncology, 2019, 29(6): 439-444.
|
| [8] |
ZHAO Yudi, TAN Fang, YAN Zhiling, LI Yingfu, DAI Shuying, ZHOU Ziyun, ZHANG Xinwen, LIU Shuyuan, SHI Li, YAO Yufeng.
Correlation between genetic variants in CD44 gene and cervical cancer and non-small cell lung cancer
[J]. China Oncology, 2019, 29(4): 277-283.
|
| [9] |
ZHOU Wei, ZHANG Zhijiang, WANG Lijun, et al.
Joinpoint regression analysis for the trends of cervical cancer mortality between 1987-2014 in China
[J]. China Oncology, 2017, 27(8): 634-640.
|
| [10] |
WAN Xiaochun, ZHOU Xiaoyan, PING bo, et al.
Preliminary prediction of the effectiveness of high-risk HPV types included 9-valent HPV vaccine in uterine cervical cancers and precancerous lesions
[J]. China Oncology, 2017, 27(7): 552-558.
|
| [11] |
FENG Dingqing, YAN Keqin, ZHANG Xiao, et al.
The role of Piwil2 in regulating the malignant process of cervical cancer
[J]. China Oncology, 2017, 27(12): 921-927.
|
| [12] |
DUAN Yachen, CHEN Xiaojun, WU Xiaohua.
Detection of HPV in peripheral blood and its clinical significance
[J]. China Oncology, 2017, 27(11): 908-912.
|
| [13] |
LIU Jian, CUI Yanyan, LI Shengze, et al.
Analysis of prognostic factors in patients with stage ⅠB2-ⅡA2 uterine cervical cancer treated with a combintion of neoadjuvant chemotherapy and surgery
[J]. China Oncology, 2016, 26(5): 427-433.
|
| [14] |
SHEN Lihua, ZHANG Zhongwei, ZHU Biao.
Clinical analysis of tumor related venous thromboembolism: 196 cases
[J]. China Oncology, 2016, 26(4): 338-345.
|
| [15] |
WU Dan, YANG Xin, ZHU Junling, et al.
Analysis of DBC1 gene promoter methylation in cervical cancer tissues of Uyghur women in Xinjiang
[J]. China Oncology, 2016, 26(3): 208-214.
|
